Camurus AB | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
197,716.00
208,207.00
154,799.00
113,737.00
54,308.00
49,321
Cost of Goods Sold (COGS) incl. D&A
2,389.00
2,085.00
3,789.00
5,664.00
5,444.00
9,190
Gross Income
195,327.00
206,122.00
151,010.00
108,073.00
48,864.00
40,131
SG&A Expense
73,457.00
146,284.00
180,873.00
211,276.00
291,334.00
328,179
EBIT
121,870.00
59,838.00
29,863.00
103,203.00
242,470.00
288,048
Unusual Expense
-
-
173,641.00
-
-
-
Non Operating Income/Expense
5,325.00
2,311.00
766.00
251.00
1,072.00
805
Pretax Income
127,267.00
62,543.00
204,268.00
103,359.00
243,368.00
287,068
Income Tax
28,032.00
14,197.00
44,726.00
22,366.00
52,794.00
52,392
Consolidated Net Income
99,235.00
48,346.00
159,542.00
80,993.00
190,574.00
234,676
Net Income
99,235.00
48,346.00
159,542.00
80,993.00
190,574.00
234,676
Net Income After Extraordinaries
99,235.00
48,346.00
159,542.00
80,993.00
190,574.00
234,676
Net Income Available to Common
99,235.00
48,346.00
159,542.00
80,993.00
190,574.00
234,676
EPS (Basic)
17.01
8.24
6.02
2.17
5.11
5.68
Basic Shares Outstanding
25,208.60
25,208.60
26,497.00
37,281.50
37,281.50
41,332.80
EPS (Diluted)
3.94
1.92
4.28
2.17
5.11
5.68
Diluted Shares Outstanding
25,208.60
25,208.60
37,281.00
37,281.50
37,281.50
41,332.80
EBITDA
122,684.00
61,267.00
26,311.00
99,679.00
238,382.00
285,680
Non-Operating Interest Income
72.00
394.00
2.00
95.00
174.00
175

About Camurus AB

View Profile
Address
Ideon Science Park
Lund SN 223 70
Sweden
Employees -
Website http://www.camurus.com
Updated 07/08/2019
Camurus AB engages in the research, development, and commercialization of specialty medicines. It provides its products for the treatment of severe and chronic conditions, which includes opioid dependence, pain, cancer, and endocrine disorders. The company was founded by Kare Larsson in 1991 and is headquartered in Lund, Sweden.